Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Atypical femoral fractures in patients taking longterm alendronate.

Mulgund M, Beattie KA, Anaspure R, Matsos M, Patel A, Adachi JD.

J Rheumatol. 2011 Dec;38(12):2686-7. doi: 10.3899/jrheum.110725. No abstract available.

PMID:
22134795
2.

Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate.

Lenart BA, Lorich DG, Lane JM.

N Engl J Med. 2008 Mar 20;358(12):1304-6. doi: 10.1056/NEJMc0707493. No abstract available.

3.

Alendronate-related femoral diaphysis fracture--what should be done to predict and prevent subsequent fracture of the contralateral side?

Edwards MH, McCrae FC, Young-Min SA.

Osteoporos Int. 2010 Apr;21(4):701-3. doi: 10.1007/s00198-009-0986-y. Epub 2009 Jun 27. Review.

PMID:
19562241
4.

Bilateral atypical femoral fractures after long-term alendronate therapy: a case report.

Bamrungsong T, Pongchaiyakul C.

J Med Assoc Thai. 2010 May;93(5):620-4.

PMID:
20524451
5.

Atypical femoral fractures associated with long-term bisphosphonate use.

Chatterjee S.

CMAJ. 2013 Oct 1;185(14):1248. doi: 10.1503/cmaj.121698. Epub 2013 May 6. No abstract available.

6.

Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Frozen bone with remodelling at the crack.

Aspenberg P, Schilcher J, Fahlgren A.

Acta Orthop. 2010 Aug;81(4):460-2. doi: 10.3109/17453674.2010.492766. No abstract available.

7.

Low-energy femoral shaft fractures associated with alendronate use.

Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG.

J Orthop Trauma. 2008 May-Jun;22(5):346-50. doi: 10.1097/BOT.0b013e318172841c.

PMID:
18448990
8.

Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution.

Goh SK, Yang KY, Koh JS, Wong MK, Chua SY, Chua DT, Howe TS.

J Bone Joint Surg Br. 2007 Mar;89(3):349-53.

PMID:
17356148
9.

Case reports: two femoral insufficiency fractures after long-term alendronate therapy.

Sayed-Noor AS, Sjödén GO.

Clin Orthop Relat Res. 2009 Jul;467(7):1921-6. doi: 10.1007/s11999-009-0725-x. Epub 2009 Feb 6.

10.

Atypical femoral fractures bilaterally in a patient receiving denosumab.

Drampalos E, Skarpas G, Barbounakis N, Michos I.

Acta Orthop. 2014 Feb;85(1):3-5. doi: 10.3109/17453674.2013.854668. Epub 2013 Oct 31. No abstract available. Erratum in: Acta Orthop. 2014 Feb;85(1):2.

11.
12.

Femoral shaft fractures in the elderly--role of prior bisphosphonate therapy.

Ng YH, Gino PD, Lingaraj K, Das De S.

Injury. 2011 Jul;42(7):702-6. doi: 10.1016/j.injury.2010.12.019. Epub 2011 Feb 11.

PMID:
21316051
13.

Spontaneous femoral shaft fracture after long-term alendronate.

Ali T, Jay RH.

Age Ageing. 2009 Sep;38(5):625-6. doi: 10.1093/ageing/afp106. Epub 2009 Jun 25.

PMID:
19556326
14.

Risk of atypical femoral fracture with long-term use of alendronate (bisphosphonates) : a systemic review of literature.

Agarwal S, Agarwal S, Gupta P, Agarwal PK, Agarwal G, Bansal A.

Acta Orthop Belg. 2010 Oct;76(5):567-71. Review.

PMID:
21138208
15.

Simultaneous bilateral atypical femoral fractures after alendronate therapy.

Zafeiris CP, Stathopoulos IP, Kourkoumelis G, Gkikas E, Lyritis GP.

J Musculoskelet Neuronal Interact. 2012 Dec;12(4):262-4. No abstract available.

16.

Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium.

Lee JK.

Int J Rheum Dis. 2009 Jul;12(2):149-54. doi: 10.1111/j.1756-185X.2009.01396.x.

PMID:
20374333
17.

Insufficiency femoral fractures in patients undergoing prolonged alendronate therapy.

Atik OS, Suluova F, Görmeli G, Yildirim A, Ali AKh.

Eklem Hastalik Cerrahisi. 2010 Apr;21(1):56-9.

18.

Non-traumatic fracture of the femoral shaft in a patient taking long-term bisphosphonate therapy.

Ahn JK, Lee J, Cha HS, Koh EM.

Rheumatol Int. 2011 Jul;31(7):973-5. doi: 10.1007/s00296-010-1477-3. Epub 2010 Apr 10. No abstract available.

PMID:
20383511
19.

An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?

Kwek EB, Goh SK, Koh JS, Png MA, Howe TS.

Injury. 2008 Feb;39(2):224-31. doi: 10.1016/j.injury.2007.08.036. Epub 2008 Jan 28.

PMID:
18222447
20.

Subtrochanteric femoral fractures in patients receiving long-term alendronate therapy: imaging features.

Chan SS, Rosenberg ZS, Chan K, Capeci C.

AJR Am J Roentgenol. 2010 Jun;194(6):1581-6. doi: 10.2214/AJR.09.3588.

PMID:
20489100

Supplemental Content

Support Center